統計調査のデータを用いた研究論文

本学会統計調査の原データを解析した、公募研究や統計調査委員会・解析小委員会が関わった研究の論文です。
（最終更新2021年7月15日）

※「PMID」をクリックすると、該当論文が表示されます。
　 「ダイジェスト版（日本語）」をクリックすると、該当論文の日本語解説が表示されます。
　　以前『わが国の慢性透析療法の現況』にも掲載したものです。

英文

2021年

• Association of kidney transplantation with mortality on hemodialysis after graft failure. Kawaguchi T, Hamano T, Masakane I, Wada A, Okada E, Kadomura M, Imasawa T. J Nephrol. 2021 Apr;34(2):521-530. doi: 10.1007/s40620-020-00929-4. Epub 2021 Jan 4.
  PMID: 33394343
• Association between anemia and mortality in hemodialysis patients is modified by the presence of diabetes. Maruyama Y, Kanda E, Kikuchi K, Abe M, Masakane I, Yokoo T, Nitta K. J Nephrol. 2021 Feb 8. doi: 10.1007/s40620-020-00879-x. Online ahead of print.
  PMID: 33555578
• Encapsulating peritoneal sclerosis and morality related to infection in patients on combination once-weekly hemodialysis with peritoneal dialysis. Murashima M, Hamano T, Abe M, Masakane I. Am J Nephrol. 2021;52(4):336-341. doi: 10.1159/000515150.
  PMID: 33895730

2020年

• Synergic Impact of Body Mass Index, Diabetes, and Age on Long-Term Mortality in Japanese Incident Hemodialysis Patients: A Cohort Study on a Large National Dialysis Registry. Toida T, Sato Y, Ogata S, Wada A, Masakane I, Fujimoto S. J Ren Nutr. 2020 Jul;30(4):333-340. doi: 10.1053/j.jrn.2019.09.007. Epub 2019 Dec 4. 　
  PMID: 31812321　
• Long-term excess mortality after hip fracture in hemodialysis patients: a nationwide cohort study in Japan. Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I. J Bone Miner Metab. 2020 Sep;38(5):718-729. doi: 10.1007/s00774-020-01110-4. Epub 2020 May 12.
  PMID: 32399676　
• Effect of uric acid levels on mortality in Japanese peritoneal dialysis patients. Sugano N, Maruyama Y, Ohno I, Wada A, Shigematsu T, Masakane I, Yokoo T, Nitta K. Perit Dial Int. 2020 Jun 5:896860820929476. doi: 10.1177/0896860820929476. Online ahead of print.
  PMID: 32500808　
• Seasonal variations in cause-specific mortality and transition to renal replacement therapy among patients with end-stage renal disease. Goto S, Hamano T, Ogata S, Masakane I. Sci Rep. 2020 Feb 11;10(1):2325. doi: 10.1038/s41598-020-59153-6.
  PMID: 32047207　
• Combination of once-weekly haemodialysis with peritoneal dialysis is associated with lower mortality compared with peritoneal dialysis alone: a longitudinal study. Murashima M, Hamano T, Abe M, Masakane I. Clin Kidney J. 2020 (in press) doi: 10.1093/ckj/sfaa173　
  PMID: 34084457　
• Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis. Fujisaki K, Joki N, Tanaka S, Kanda E, Hamano T, Masakane I, Tsuruya K. Kidney Int Rep. 2020 Dec 29;6(2):342-350. doi: 10.1016/j.ekir.2020.11.009. eCollection 2021 Feb.
  PMID: 33615059　
• Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan. Kanda E, Epureanu BI, Adachi T, Tsuruta Y, Kikuchi K, Kashihara N, Abe M, Masakane I, Nitta K. PLoS One. 2020 May 29;15(5):e0233491. doi: 10.1371/journal.pone.0233491. eCollection 2020.
  PMID: 32469924　
• Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study. Hoshino J, Abe M, Hamano T, Hasegawa T, Wada A, Ubara Y, Takaichi K, Nakai S, Masakane I, Nitta K. BMJ Open Diab Res Care 2020;8:e001642. doi:10.1136/bmjdrc-2020-001642　
  PMID: 33099507　
• Calculation of expected remaining lifetime of dialysis patients in Japan. Nakai S, Wada A, Wakai K, Abe M, Nitta K. Ren Replace Ther 2020;6:58. doi.org/10.1186/s41100-020-00301-z

2019年

• Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study. Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I. Nephrol Dial Transplant. 2019 Jul 1;34(7):1207-1216. doi: 10.1093/ndt/gfy253.
  PMID: 30124993　
• Hemodialysis Product and Hip Fracture in Hemodialysis Patients: A Nationwide Cohort Study in Japan. Wakasugi M, Kazama JJ, Kikuchi K, Yasuda K, Wada A, Hamano T, Masakane I, Narita I. Ther Apher Dial. 2019 Dec;23(6):507-517. doi: 10.1111/1744-9987.12807. Epub 2019 May 8.
  PMID: 30941869　
• The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry. Nishiwaki H, Hasegawa T, Koiwa F, Hamano T, Masakane I. PLoS One. 2019 Jan 10;14(1):e0210533. doi: 10.1371/journal.pone.0210533. eCollection 2019.
  PMID: 30629677　
• Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study. Sugano N, Maruyama Y, Kidoguchi S, Ohno I, Wada A, Shigematsu T, Masakane I, Yokoo T. PLoS One. 2019 Jun 6;14(6):e0217859. doi: 10.1371/journal.pone.0217859. eCollection 2019.
  PMID: 31170241　
• Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis. Kikuchi K, Hamano T, Wada A, Nakai S, Masakane I. Kidney Int. 2019 Apr;95(4):929-938. doi: 10.1016/j.kint.2018.10.036. Epub 2019 Feb 16.
  PMID: 30782421　
• Comparison of accuracy between pre-hemodialysis and post-hemodialysis levels of nutritional factors for prediction of mortality in hemodialysis patients. Kanno Y, Kanda E. Clin Nutr. 2019 Feb;38(1):383-388. doi: 10.1016/j.clnu.2017.12.012. Epub 2017 Dec 21.
  PMID: 29295748　
• Types of Erythropoietin-Stimulating Agents and Mortality among Patients Undergoing Hemodialysis. Sakaguchi Y, Hamano T, Wada A, Masakane I. J Am Soc Nephrol. 2019 Jun;30(6):1037-1048. doi: 10.1681/ASN.2018101007. Epub 2019 Apr 23.
  PMID: 31015255　
• Use of vasopressor for dialysis-related hypotension is a risk factor for death in hemodialysis patients: Nationwide cohort study. Kanda E, Tsuruta Y, Kikuchi K, Masakane I. Sci Rep. 2019 Mar 4;9(1):3362. doi: 10.1038/s41598-019-39908-6.
  PMID: 30833633　
• Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study. Abe M, Hamano T, Hoshino J, Wada A, Nakai S, Hanafusa N, Masakane I, Nitta K, Nakamoto H. Sci Rep. 2019 Mar 8;9(1):3967. doi: 10.1038/s41598-019-40692-6.
  PMID: 30850727
• Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study. Abe M, Hamano T, Hoshino J, Wada A, Nakai S, Masakane I. Sci Rep. 2019 Mar 1;9(1):3320. doi: 10.1038/s41598-019-39933-5.
  PMID: 30824808　
• A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study. Kanda E, Kato A, Masakane I, Kanno Y. PLoS One. 2019 Mar 28;14(3):e0214524. doi: 10.1371/journal.pone.0214524. eCollection 2019.
  PMID: 30921398　

2018年

• Is hemodialysis itself a risk factor for dementia? An analysis of nationwide registry data of patients on maintenance hemodialysis in Japan? Nakai S, Wakai K, Kanda E, Kawaguchi K, Sakai K, Kitaguchi N.　Ren Replace Ther 2018;4:12. doi.org/10.1186/s41100-018-0154-y
• Higher dialysate calcium concentration is associated with incident myocardial infarction among diabetic patients with low bone turnover: a longitudinal study. Tagawa M, Hamano T, Sueta S, Ogata S, Saito Y. Sci Rep. 2018 Jul 3;8(1):10060. doi: 10.1038/s41598-018-28422-w.
  PMID: 29968801　
• Salt Intake and All-Cause Mortality in Hemodialysis Patients. Ikenoue T, Koike K, Fukuma S, Ogata S, Iseki K, Fukuhara S. Am J Nephrol. 2018;48(2):87-95. doi: 10.1159/000492034. Epub 2018 Aug 7.
  PMID: 30086543　
• Hip Fracture Trends in Japanese Dialysis Patients, 2008-2013. Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I. Am J Kidney Dis. 2018 Feb;71(2):173-181. doi: 10.1053/j.ajkd.2017.07.017. Epub 2017 Nov 20.
  PMID: 29162337　
• Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study. Hoshino J, Hamano T, Abe M, Hasegawa T, Wada A, Ubara Y, Takaichi K, Inaba M, Nakai S, Masakane I; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant. 2018 Jul 1;33(7):1150-1158. doi: 10.1093/ndt/gfy014.
  PMID: 29528439　
• Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis. Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I. J Am Soc Nephrol. 2018 Mar;29(3):991-999. doi: 10.1681/ASN.2017080849. Epub 2017 Nov 30.
  PMID: 29191960　
• Rate of the "burnt-out diabetes" phenomenon in patients on peritoneal dialysis. Abe M, Hamano T, Hoshino J, Wada A, Nakai S, Masakane I. Diabetes Res Clin Pract. 2018 Sep;143:254-262. doi: 10.1016/j.diabres.2018.07.026. Epub 2018 Jul 27.
  PMID: 30056189　　

2017年

• Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching. Obi Y, Hamano T, Wada A, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Sci Rep. 2017 Jan 31;7:41170. doi: 10.1038/srep41170.
  PMID: 28139665　ダイジェスト版（日本語）
• Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis? Abe M, Hamano T, Hoshino J, Wada A, Inaba M, Nakai S, Masakane I. Diabetes Res Clin Pract. 2017 Aug;130:211-220. doi: 10.1016/j.diabres.2017.06.012. Epub 2017 Jun 13.
  PMID: 28648854　ダイジェスト版（日本語）　
• High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry. Abe M, Hamano T, Wada A, Nakai S, Masakane I. Am J Nephrol. 2017;46(1):82-92. doi: 10.1159/000478032. Epub 2017 Jul 4.
  PMID: 28675885　 ダイジェスト版（日本語）
• Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry. Abe M, Hamano T, Wada A, Nakai S, Masakane I; Renal Data Registry Committee, Japanese Society for Dialysis Therapy. PLoS One. 2017 Sep 14;12(9):e0184424. doi: 10.1371/journal.pone.0184424. eCollection 2017.
  PMID: 28910324　　

2016年

• Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients. Sakao Y, Ojima T, Yasuda H, Hashimoto S, Hasegawa T, Iseki K, Tsubakihara Y, Kato A. PLoS One. 2016 Mar 1;11(3):e0150003. doi: 10.1371/journal.pone.0150003. eCollection 2016.
  PMID: 26930325　　
• Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry. Yazawa M, Kido R, Ohira S, Hasegawa T, Hanafusa N, Iseki K, Tsubakihara Y, Shibagaki Y. PLoS One. 2016 Jun 7;11(6):e0156951. doi: 10.1371/journal.pone.0156951. eCollection 2016.
  PMID: 27270615　
• Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients. Sumida K, Yamagata K, Iseki K, Tsubakihara Y. Nephrol Dial Transplant. 2016 Feb;31(2):298-305. doi: 10.1093/ndt/gfv402. Epub 2015 Dec 13.
  PMID: 26666499　
• Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010. Hoshino J, Yamagata K, Nishi S, Nakai S, Masakane I, Iseki K, Tsubakihara Y. Nephrol Dial Transplant. 2016 Apr;31(4):595-602. doi: 10.1093/ndt/gfv276. Epub 2015 Jul 22.
  PMID: 26206763 　ダイジェスト版（日本語）　

2015年

• Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M. Kidney Int. 2015 Aug;88(2):350-9. doi: 10.1038/ki.2015.72. Epub 2015 Mar 18.
  PMID: 25786097　ダイジェスト版（日本語）
• Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients. Yamamoto T, Shoji S, Yamakawa T, Wada A, Suzuki K, Iseki K, Tsubakihara Y. Am J Kidney Dis. 2015 Sep;66(3):469-78. doi: 10.1053/j.ajkd.2015.04.014. Epub 2015 May 23.
  PMID: 26015276　ダイジェスト版（日本語）　
• Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients. Shoji T, Marubayashi S, Shigematsu T, Iseki K, Tsubakihara Y; Committee of Renal Data Registry; Japanese Society for Dialysis Therapy. Ther Apher Dial. 2015 Jun;19(3):235-44. doi: 10.1111/1744-9987.12274. Epub 2014 Dec 19.
  PMID: 25530222　ダイジェスト版（日本語）　
• Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Hasegawa T, Nakai S, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y, Akizawa T. Am J Kidney Dis. 2015 Jun;65(6):899-904. doi: 10.1053/j.ajkd.2014.12.009. Epub 2015 Jan 30.
  PMID: 25641063　ダイジェスト版（日本語）
• Institutional factors influencing regional differences in the 1-year survival of dialysis patients. Ogata S, Nishi S, Wakai K, Hanafusa N, Iseki K, Tsubakihara Y, Masakane I. Hemodial Int. 2015 Oct;19 Suppl 3:S5-10. doi: 10.1111/hdi.12346.
  PMID: 26448388　ダイジェスト版（日本語）　
• The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry. Maruyama Y, Yokoyama K, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y. PLoS One. 2015 Nov 23;10(11):e0143430. doi: 10.1371/journal.pone.0143430. eCollection 2015.
  PMID: 26599216　ダイジェスト版（日本語）
• Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry. Hamano T, Fujii N, Hayashi T, Yamamoto H, Iseki K, Tsubakihara Y. Kidney Int Suppl (2011). 2015 Jun;5(1):23-32. doi: 10.1038/kisup.2015.6.
  PMID: 26097782　ダイジェスト版（日本語）　

2014年

• Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study. Tagawa M, Hamano T, Nishi H, Tsuchida K, Hanafusa N, Fukatsu A, Iseki K, Tsubakihara Y. PLoS One. 2014 Dec 10;9(12):e114678. doi: 10.1371/journal.pone.0114678. eCollection 2014.
  PMID: 25494334　ダイジェスト版（日本語）
• A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Maruyama Y, Taniguchi M, Kazama JJ, Yokoyama K, Hosoya T, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y. Nephrol Dial Transplant. 2014 Aug;29(8):1532-8. doi: 10.1093/ndt/gfu055. Epub 2014 Mar 18.
  PMID: 24642419　ダイジェスト版（日本語）
• Regional variation in hip fracture incidence among Japanese hemodialysis patients. Wakasugi M, Kazama JJ, Wada A, Taniguchi M, Tsubakihara Y, Iseki K, Narita I. Ther Apher Dial. 2014 Apr;18(2):162-6. doi: 10.1111/1744-9987.12074. Epub 2013 Aug 27.
  PMID: 24720407　ダイジェスト版（日本語）
• Associations among epoetin therapy, inflammation, nutritional status, and mortality in patients on hemodialysis. Honda H, Kimata N, Wakai K, Akizawa T. J Ren Nutr. 2014 Sep;24(5):322-9. doi: 10.1053/j.jrn.2014.03.009. Epub 2014 Jul 10.
  PMID: 25023457　
• Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Iseki K, Tsubakihara Y, Isaka Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. PLoS One. 2014 Dec 29;9(12):e116273. doi: 10.1371/journal.pone.0116273. eCollection 2014.
  PMID: 25545498　ダイジェスト版（日本語）　
• Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Kidney Int. 2014 Jan;85(1):174-81. doi: 10.1038/ki.2013.327. Epub 2013 Aug 28.
  PMID: 23986148　ダイジェスト版（日本語）
• Carpal tunnel surgery as proxy for dialysis-related amyloidosis: results from the Japanese society for dialysis therapy. Hoshino J, Yamagata K, Nishi S, Nakai S, Masakane I, Iseki K, Tsubakihara Y. Am J Nephrol. 2014;39(5):449-58. doi: 10.1159/000362567. Epub 2014 May 10.
  PMID: 24819459　ダイジェスト版（日本語）

2013年

• Increased risk of hip fracture among Japanese hemodialysis patients. Wakasugi M, Kazama JJ, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Narita I. J Bone Miner Metab. 2013 May;31(3):315-21. doi: 10.1007/s00774-012-0411-z. Epub 2013 Jan 6.
  PMID: 23292163　ダイジェスト版（日本語）　
• Factors associated with the incidence of dialysis. Ogata S, Nishi S, Wakai K, Iseki K, Tsubakihara Y. Clin Exp Nephrol. 2013 Dec;17(6):890-8. doi: 10.1007/s10157-013-0786-8. Epub 2013 Mar 20.
  PMID: 23512646　ダイジェスト版（日本語）
• Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Ther Apher Dial. 2013 Apr;17(2):221-8. doi: 10.1111/1744-9987.12030.
  PMID: 23551679　ダイジェスト版（日本語）

2012年

• Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients: results from a cohort study from the dialysis registry in Japan. Fukuma S, Yamaguchi T, Hashimoto S, Nakai S, Iseki K, Tsubakihara Y, Fukuhara S. Am J Kidney Dis. 2012 Jan;59(1):108-16. doi: 10.1053/j.ajkd.2011.07.014. Epub 2011 Sep 3.
  PMID: 21890255　ダイジェスト版（日本語）　
• Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry. Yamagata K, Nakai S, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Ther Apher Dial. 2012 Apr;16(2):111-20. doi: 10.1111/j.1744-9987.2011.01052.x.
  PMID: 22458388　ダイジェスト版（日本語）
• Ideal timing and predialysis nephrology care duration for dialysis initiation: from analysis of Japanese dialysis initiation survey. Yamagata K, Nakai S, Masakane I, Hanafusa N, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Ther Apher Dial. 2012 Feb;16(1):54-62. doi: 10.1111/j.1744-9987.2011.01005.x. Epub 2011 Nov 3.
  PMID: 22248196　ダイジェスト版（日本語）

2011年

• Environmental factors influencing the survival of chronic dialysis patients. Ogata S, Yorioka N. Clin Exp Nephrol. 2011 Jun;15(3):405-409. doi: 10.1007/s10157-010-0400-2. Epub 2011 Jan 20.
  PMID: 21249416
• Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Shoji T, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y; Committee of Renal Data Registry, Japanese Society for Dialysis Therapy. Clin J Am Soc Nephrol. 2011 May;6(5):1112-20. doi: 10.2215/CJN.09961110. Epub 2011 Apr 21.
  PMID: 21511840　ダイジェスト版（日本語）　
• Tachycardia as a predictor of poor survival in chronic haemodialysis patients. Iseki K, Nakai S, Yamagata K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant. 2011 Mar;26(3):963-9. doi: 10.1093/ndt/gfq507. Epub 2010 Sep 3.
  PMID: 20817672　ダイジェスト版（日本語）

2010年

• Specialist care and improved long-term survival of dialysis patients. Furumatsu Y, Nagasawa Y, Yamamoto R, Iio K, Iwatani H, Matsui I, Takabatake Y, Kawada N, Shoji T, Imai E, Isaka Y, Rakugi H. Nephrol Dial Transplant. 2010 Jun;25(6):1930-5. doi: 10.1093/ndt/gfp738. Epub 2010 Jan 8.
  PMID: 20061314　

2009年

• Genetic and environmental effects and characteristics of Japanese end-stage renal disease patients. Ogata S, Yorioka N, Gilbertson DT, Chen SC, Foley RN, Collins AJ. Hemodial Int. 2009 Oct;13 Suppl 1:S8-12. doi: 10.1111/j.1542-4758.2009.00412.x.
  PMID: 19775423　

和文

2019年

• 頻回・長時間透析の現状と展望　統計調査(JRDR予後解析からみた頻回・長時間透析の至適透析量) ．安田香、政金生人　透析会誌．2019；52(9)：527-530　
  J-STAGE　

2012年

• 透析条件・透析量と生命予後-患者背景別の検討-．鈴木一之、井関邦敏、中井滋、木全直樹、守田治、伊丹儀友、椿原美治．透析会誌．2012；45(2)：143-155
  J-STAGE　
• わが国の慢性維持透析人口将来推計の試み．中井滋、若井建志、山縣邦弘、井関邦敏、椿原美治．透析会誌．2012；45(7)：599-613
  J-STAGE　

2011年

• 慢性透析患者の地域差の要因－日本透析医学会統計調査委員会研究－．尾形　聡、西　慎一、若井建志、井関邦敏、椿原美治．2011；44(8)：681-688
  J-STAGE